Literature DB >> 1350312

Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids.

R L Hayes1, L W Jenkins, B G Lyeth.   

Abstract

Research into traumatic brain injury (TBI), focusing on changes in energy metabolism, cerebrovascular dysfunction, and brain parenchymal morphology, has not produced complete descriptions of mechanisms mediating the pathophysiology of TBI. New studies indicate that neurochemical alterations mediate important components of brain physiology associated with TBI, and these alterations may be responsive to pharmacologic therapy. We discuss rodent models of TBI, review current experimental evidence of muscarinic cholinergic and excitatory amino acid (EAA) receptor involvement in its pathophysiology, and address issues relevant to the interpretation of these data.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350312

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  36 in total

1.  Hibernation, a model of neuroprotection.

Authors:  F Zhou; X Zhu; R J Castellani; R Stimmelmayr; G Perry; M A Smith; K L Drew
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 2.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 3.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

4.  Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact.

Authors:  Ashley R Kochanek; Anthony E Kline; Wei-Min Gao; Mandeep Chadha; Yichen Lai; Robert S B Clark; C Edward Dixon; Larry W Jenkins
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

5.  Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome.

Authors:  Jing Zhao; Michael J Hylin; Nobuhide Kobori; Kimberly N Hood; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2017-12-18       Impact factor: 5.269

Review 6.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

7.  Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  Yanlu Zhang; Zheng Gang Zhang; Michael Chopp; Yuling Meng; Li Zhang; Asim Mahmood; Ye Xiong
Journal:  J Neurosurg       Date:  2016-05-20       Impact factor: 5.115

8.  Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons.

Authors:  Y Cheng; A Y Sun
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

9.  The effect of hypothermia on the expression of TIMP-3 after traumatic brain injury in rats.

Authors:  Feng Jia; Qing Mao; Yu-Min Liang; Ji-Yao Jiang
Journal:  J Neurotrauma       Date:  2012-12-20       Impact factor: 5.269

10.  Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus.

Authors:  Cynthia J Gibson; Rebecca C Meyer; Robert J Hamm
Journal:  J Biomed Sci       Date:  2010-05-18       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.